Volume 2.07 | Feb 26

Intestinal Cell News 2.07 February 26, 2016
Intestinal Cell News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  ICN on Twitter
 
TOP STORY
Transcriptional Reprogramming and Resistance to Colonic Mucosal Injury in Poly(ADP-Ribose) Polymerase 1 (PARP1)-Deficient Mice
Researchers identified REGγ-mediated control of IκBε as a molecular mechanism that contributes to NFκB activation and promotes bowel inflammation and associated tumor formation in response to chronic injury. [Nat Commun] Full Article
Watch Now: Webinar on Gastrointestinal Organoids by Dr. Meritxell Huch
 
PUBLICATIONS (Ranked by impact factor of the journal)
INTESTINAL CANCERS & DISEASES

Tumor Suppressive Role of Sestrin2 during Colitis and Colon Carcinogenesis
Investigators showed that human SESN2 expression is elevated in the colon of ulcerative colitis patients but is lost upon p53 inactivation during colon carcinogenesis. [eLife] Full Article | Download Full Article

Novel Role of STRAP in Progression and Metastasis of Colorectal Cancer through Wnt/β-Catenin Signaling
Researchers showed the molecular mechanism by which Serine-Threonine Kinase Receptor-Associated Protein (STRAP) induces colorectal cancer metastasis by promoting β-catenin signaling through its stabilization. [Oncotarget] Full Article

Long Non-Coding RNA MALAT1 Increases AKAP-9 Expression by Promoting SRPK1-Catalyzed SRSF1 Phosphorylation in Colorectal Cancer Cells
Researchers investigated the molecular mechanism by which MALAT1 enhances AKAP9 expression in colorectal cancer SW480 cells. They found that MALAT1 interacts with both SRPK1 and SRSF1. [Oncotarget] Full Article

The miR-27a-Calreticulin Axis Affects Drug-Induced Immunogenic Cell Death in Human Colorectal Cancer Cells
The authors sought to verify whether miR-27a is implicated in immunogenic cell death, having demonstrated that it directly targets calreticulin. [Cell Death Dis] Full Article

The Activation of ERK1/2 and JNK MAPK Signaling by Insulin/IGF-1 Is Responsible for the Development of Colon Cancer with Type 2 Diabetes Mellitus
The authors investigated the effects and mechanisms of insulin and insulin-like growth factor 1 (IGF-1) in colon cancer development in vitro and in vivo. Insulin and IGF-1 alone or together elevated proliferation and reduced apoptosis in colon cancer MC38 cells. [PLoS One] Full Article

INTESTINAL STEM CELL & ORGANOID RESEARCH

Sex Difference in Pathology of the Aging Gut Mediates the Greater Response of Female Lifespan to Dietary Restriction
Investigators uncovered a substantial sex difference in the pathology of the aging gut in Drosophila. The intestinal epithelium of the aging female undergoes major deterioration, driven by intestinal stem cell (ISC) division, while lower ISC activity in males associates with delay or absence of pathology, and better barrier function, even at old ages. [eLife] Full Article

Quantifying Lgr5-Positive Stem Cell Behavior in the Pyloric Epithelium
Using in vivo lineage tracing data researchers quantified clonal expansion as well as proliferation and differentiation of the Lgr5-positive stem cell population in pyloric gastric glands. [Sci Rep] Full Article

A Versatile Strategy for Isolating a Highly Enriched Population of Intestinal Stem Cells
Scientists introduce a combinational cell surface marker-mediated strategy that allows the isolation of an intestinal stem cell (ISC) population transcriptionally and functionally equivalent to the gold standard Lgr5-GFP ISCs. [Stem Cell Reports] Full Article | Graphical Abstract

Learn More: STEMdiff™ Pancreatic Progenitor Kit
 
REVIEWS
Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease
The authors discuss how novel insights into the mechanism of action of anti-TNFs in Crohn’s disease may contribute to the development of novel anti-TNFs with improved efficacy. [J Crohns Colitis] Abstract

Visit our reviews page to see a complete list of reviews in the intestinal cell research field.
 
INDUSTRY NEWS
TiGenix Obtains Commercial Production License for Cx601
TiGenix NV announced that it has successfully obtained the license for commercial production of Cx601, TiGenix’s product for the treatment of complex perianal fistulas in Crohn’s disease patients. [TiGenix NV] Press Release

Atlantic Healthcare Starts Pivotal Phase III trial of Alicaforsen to Treat Inflammatory Bowel Disease Pouchitis
Atlantic Healthcare Plc announced that patient recruitment has commenced for a Phase III trial of its wholly-owned product alicaforsen enema to treat inflammatory bowel disease pouchitis. [Atlantic Healthcare plc] Press Release

Government of Canada Invests in Research Commercialization
The Centre for Commercialization of Cancer Immunotherapy will receive funding of $15 million over five years to develop, translate and commercialize cancer immunotherapy. [Networks of Centres of Excellence of Canada] Press Release

From our sponsor: 3D intestinal organoid culture is made easy with IntestiCult™. Request a sample.
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW European Society for Medical Oncology (ESMO) 2016
October 7-11, 2016
Copenhagen, Denmark

Visit our events page to see a complete list of events in the intestinal cell research community.
 
JOB OPPORTUNITIES
NEW Faculty Position – Cancer Research (Texas Tech University Health Sciences Center)

Postdoctoral Position – Immunology of Inflammatory Bowel Disease (University of California, San Diego)

Postdoctoral Fellowship – Inflammatory Bowel Disease (Linköping University)

Postdoctoral Position – Tumor Immunology (Medical University of South Carolina)

Research Associate – Autoimmunity (The Scripps Research Institute)

Postdoctoral Fellowship – Immunology (Beth Israel Deaconess Medical Center)

Gastroenterologist – Inflammatory Bowel Disease (Mayo Clinic)

Postdoctoral Associate – Biomedical and Single Cell Genomics (Cornell University)

Faculty Position – Gastrointestinal Physiology (University of Ottawa)

Postdoctoral Position – Gut Inflammation and IBD (University College Cork)


Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Intestinal Cell News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Intestinal Cell News: Archives | Events | Contact Us